Use of programmed death ligand 1 binding molecule in drug combination for improving stability of protein-drug conjugate preparations, and treating advanced or metastatic solid malignant tumor
程序性死亡配体1结合分子在药物组合中用于提高蛋白-药物偶联物制剂稳定性及治疗晚期或转移性实体恶性肿瘤的用途
📄 英文摘要 English Abstract
Protein based nanoparticles for pulmonary drug delivery: advances, challenges, and future perspectives Journal Of Nanoparticle Research Pulmonary drug delivery has been a candidate for the treatment of respiratory disorders with a large surface area, high rate of drug absorption, and prevention of first-pass metabolism. Of the different nanocarrier systems that have b...
📄 中文摘要 Chinese Abstract
📋 英文结构化总结 English Structured Summary
摘要整理
Background:
Pulmonary drug delivery has been a candidate for the treatment of respiratory disorders with a large surface area, high rate of drug absorption, and prevention of first-pass metabolism.
Methods:
Not provided in the extracted text.
Results:
Not provided in the extracted text.
Data Summary:
Not provided in the extracted text.
Conclusions:
Not provided in the extracted text.
Practical Significance:
Not provided in the extracted text.
📋 中文结构化总结 Chinese Structured Summary
背景:
肺部给药因其具有较大的表面积、较高的药物吸收率以及可避免首过效应等优势，已成为治疗呼吸系统疾病的候选给药途径。
方法:
所提取文本中未提供。
结果:
所提取文本中未提供。
数据摘要:
所提取文本中未提供。
结论:
所提取文本中未提供。
实际意义:
所提取文本中未提供。